Sanofi-Aventis
WHO to review Sanofi’s dengue vaccine Dengvaxia over safety concerns
05 Dec 2017
The review comes after the French pharma giant’s own admission that its dengue vaccine could have unintended consequences in patients who had never been infected with the mosquito-borne virus and the Philippines halted its use
FDA approves Dupixent to treat severe eczema
29 Mar 2017
